Mark F. Brady

1 ta ish

Gynecologic Oncology Group

1. Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer

   Robert A. Burger, Mark F. Brady, Michael A. Bookman +10

   Maqola20113 iqtibos

   ABIABI:AkademIndex/2026.other.445630